Sponsor pipeline

Abeona Therapeutics, Inc clinical trial pipeline

Data updated daily from ClinicalTrials.gov, last refresh 2026-10-16

Active trials by phase

Phase 3		1
Phase 4		1

Not charted: 2 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

NCT ID	Title	Condition	Status	Updated
Phase 4
NCT07717736	Phase 4 Master Protocol for Patients Prescribed Prademagene Zamikeracel for the Treatment…	Epidermolysis Bullosa (EB)	Not Yet Recruiting	2026-08-06
Phase 3
NCT05725018	A Phase 3b Study for the Treatment of Dystrophic Epidermolysis Bullosa (DEB) in New and…	Epidermolysis Bullosa	Active, Not Recruiting	2025-06-27
Not specified
NCT07700966	A Long-Term Safety Follow-up Registry for Patients Who Received Treatment With…	Recessive Dystrophic Epidermolysis Bullosa	Recruiting	2026-07-14
NCT05708677	A Long-Term Extension Study for Participants Previously Treated With EB-101 for the…	RDEB	Enrolling by Invitation	2026-07-17

Get alerts when Abeona Therapeutics, Inc's trials change

Status changes, date slips, and new filings: detected daily, delivered to your inbox.